A story covers results of a new therapy for dermatitis reported by Eric Simpson, M.D., during the American Academy of Dermatology annual meeting in Boston.

Ahmad Masri, M.D., will present an updated analysis of a clinical trial involving patients with symptomatic transthyretin amyloid cardiomyopathy on April 3 during a conference of the American College of Cardiology.

Oregon State University has received a $5.6 million five-year grant from the National Institutes of Health to launch a research center devoted to the creation of novel proteins with disease-fighting potential. Among others, the center will benefit a project led by Eric Gouaux, Ph.D., into depression and other mood disorders.

Oregon will no longer require state residency to allow terminally ill people to receive lethal medication prescribed by a doctor, the Associated Press reports in a story picked up by outlets across the country; Nicholas Gideonse, M.D., says: “Any restriction on medical aid in dying that doesn’t serve a specific medical purpose is difficult. In no other way is my practice restricted to Oregon residents, whether that’s delivering babies in the past or other care that I provide.”

Story cites OHSU research published in the journal Science Immunology in January that found extremely high levels of immune response through hybrid immunity

In a story about an often-misdiagnosed condition involving the layering of toenails, Phoebe Rich, M.D., says, “The layering might not be visible without removing the nail."

In a story about screening for skin cancer and melanoma, Sancy Leachman, M.D., Ph.D., says: “If you’re doing those appropriate screenings, you’ll likely detect the cancer as early as you possibly can. And everyone knows that tends to give you an advantage when it comes to treatment.

A story on a patient handout provided by the Doernbecher Gender Clinic.

A career expo hosted by Eastern Oregon University, featuring opportunity’s for OHSU nursing students at EOU.

New OHSU systematic evidence review that finds a lack of research describing interactions between psychiatric medications and psychedelics like psilocybin and MDMA.